Abivax Announces Launch of Public Offering of American Depositary Shares
Abivax announced the launch of a $600M public offering of American Depositary Shares to fund the potential commercialization of obefazimod and ongoing clinical trials. The underwriters have been granted a 30-day option to purchase up to 15% additional shares to cover over-allotments.
Key figures
- Deal Value Usd
- 600000000
- Lockup period
- 60 days
- Greenshoe option
- 15%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.